Garland Rolling Circle Amplification Mediated Self-Priming Extension Strategy for Sensitive and Label-Free

Yuechen Xu1, Lingyun Wei2

  • 1Department of Operation Room, The First People's Hospital of Linping District, Hangzhou City, Zhejiang Province 311100, P. R. China.

Insights

A new biosensing strategy enables sensitive, label-free detection of Pseudomonas aeruginosa (P. aeruginosa) using aptamers and isothermal amplification. This rapid assay is promising for perioperative point-of-care testing to combat healthcare-associated infections.

Area of Science:

  • Biomedical Engineering
  • Molecular Diagnostics
  • Infectious Disease Detection

Background:

  • Early detection of Pseudomonas aeruginosa (P. aeruginosa) is crucial in perioperative care to prevent severe infections.
  • Current methods can be time-consuming and require complex procedures like nucleic acid extraction.

Purpose of the Study:

  • To develop a novel, sensitive, and label-free biosensing strategy for rapid P. aeruginosa detection.
  • To enable timely antimicrobial intervention and improve patient outcomes in perioperative settings.

Main Methods:

  • Integration of F23 aptamer for target recognition, rolling circle amplification (RCA) for signal amplification, and SYBR Green I for fluorescence readout.
  • Utilized magnetic nanoparticles for probe immobilization and a nicking endonuclease for enhanced DNA fragmentation and subsequent amplification.
  • Isothermal amplification and label-free detection approach.

Main Results:

  • Achieved a low detection limit of 2.3 CFU/mL for P. aeruginosa with a wide linear range (10-10^6 CFU/mL).
  • Demonstrated excellent specificity, stability, and anti-interference capabilities in clinical samples.
  • Validated results against the gold-standard method with reduced assay time (<2.5 hours) and without nucleic acid extraction or thermal cycling.

Conclusions:

  • The proposed aptamer-based biosensing strategy offers a rapid, sensitive, and simple method for P. aeruginosa detection.
  • This approach holds significant potential for point-of-care testing in perioperative settings.
  • The platform is adaptable for detecting other bacterial pathogens by modifying the aptamer component.

Related Concept Videos